Clinical Trial Update: Open Label Trial of Acamprosate in Bipolar Alcoholics [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 study evaluating acamprosate in individuals with alcohol dependence and bipolar disorder, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Bipolar Disorder

Drugs mentioned

• Campral (acamprosate)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence, Bipolar Disorder | Phase 1, Phase 2 | Status: COMPLETED